Substance / Medication

Betamethasone valerate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

145 trials linked to this intervention

145
Total Trials
25
Recruiting
61
With Results

Research Evidence

Published studies and systematic reviews

Sort:
308 nm-Excimer light together with topical betamethasone valerate in treating alopecia areata.
Tawfik Yasmin M, Hofny Eman R M, Zidan Fatma Magdy et al. · Arch Dermatol Res · 2025
PMID: 39912941RCT
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
El-Ashmawy Amal Ahmad, El-Maadawy Iman Hamed, El-Maghraby Gamal Mohamed · J Dermatolog Treat · 2018
PMID: 28521549RCT
Is half strength of 0.05 % betamethasone valerate cream still effective in the treatment of phimosis in young children?
Sookpotarom Paiboon, Asawutmangkul Chanchuree, Srinithiwat Benjaporn et al. · Pediatr Surg Int · 2013
PMID: 23292538RCT
A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.
Pacifico A, Daidone R, Peris K · J Eur Acad Dermatol Venereol · 2006
PMID: 16441622RCT
Development and validation of an UHPLC method for the determination of betamethasone valerate in cream, gel, ointment and lotion.
Solon Lílian Grace da Silva, Lima Igor Prado de Barros, Nogueira Fernando Henrique Andrade et al. · Steroids · 2016
PMID: 26708266Observational
Spectrophotometric methods for simultaneous determination of betamethasone valerate and fusidic acid in their binary mixture.
Lotfy Hayam Mahmoud, Salem Hesham, Abdelkawy Mohammad et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2015
PMID: 25615682Observational
Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis.
Chittock John, Brown Kirsty, Cork Michael J et al. · Acta Derm Venereol · 2015
PMID: 25594610Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Betamethasone valerate (substance)
SNOMED CT
396005002
UMLS CUI
C0750848

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

5
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
145
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.